CHROMOCELL THERAPEUTICS CORPORATION EMPLOYMENT AGREEMENTEmployment Agreement • January 20th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • New York
This Employment Agreement (the “Agreement”) is made and entered into this 9th day of January, 2023 (the “Effective Date”) by and between Chromocell Therapeutics Corporation (“CTC” or the “Company”) and Christian Kopfli, an individual who resides at 44 Gramercy Park North, New York City, NY (“Executive”). Collectively, the Company and Executive may be referred to herein as the “Parties” or each individually as a “Party.”
CHROMOCELL THERAPEUTICS CORPORATION CONSULTANT AGREEMENTConsultant Agreement • January 20th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • New York
This Consultant Agreement (the “Agreement”) is made and entered into this 9th day of January, 2023 (the “Effective Date”) by and between Chromocell Therapeutics Corporation (“CTC” or the “Company”) and Camden Capital LLC (“Consultant”). Collectively, the Company and Consultant may be referred to herein as the “Parties” or each individually as a “Party.”
CONTRIBUTION AGREEMENTContribution Agreement • January 20th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • Delaware
This CONTRIBUTION AGREEMENT (this “Agreement”) is made as of August 10, 2022, effective as of July 12, 2022 (the “Effective Date”) between Chromocell Corporation, a Delaware corporation (“Chromocell Holding” or “Contributor”) and Chromocell Therapeutics Corporation, a Delaware corporation (the “Company” or “Recipient”). Chromocell Holding and the Company are collectively referred to herein as the “Parties.” Defined terms used in this Agreement which are not elsewhere defined are defined in Section E(xii) hereof.
